Pivotal trial of monoclonal antibody TNT-1 in patients with glioblastoma.
Not yet recruiting
Phase of Trial: Phase III
Latest Information Update: 05 Dec 2012
At a glance
- Drugs Iodine I 131 derlotuximab biotin (Primary)
- Indications Glioblastoma
- Focus Registrational; Therapeutic Use
- 05 Dec 2012 Status changed from planning to not yet recruiting. The trial design has been approved by the US FDA.
- 19 Dec 2011 New trial record